Beste apotheek van Nederland

Douglass M A, Lin J C. Update on the treatment of benign
prostatic hyperplasia. Hosp Formul 2005;40(2):50-64.
Droupy S, Ponsot Y, Giuliano F. How, why and when should
urologists evaluate male sexual function?. Nature Clinical
Practice Urology 2006;3(2):84-94.
Duckworth K. Running an erectile dysfunction clinic.[see
comment]. Pap Natl Conf Prof Nurses Physicians
1997;12(11):775-778.
Dunsmuir W D, Holmes S A. The aetiology and management of
erectile, ejaculatory, and fertility problems in men with diabetes
mellitus. [Review] [96 refs]. Diabet Med 1996;13(8):700-708.
Eardley I. Vardenafil: a new oral treatment for erectile
dysfunction. [Review] [20 refs]. Int J Clin Pract 2004;58(8):801­
806.
Eardley I, Cartledge J. Tadalafil (Cialis) for men with erectile
dysfunction.[see comment]. Int J Clin Pract 2002;56(4):300-304.
Ebert T. Clinical experiences with testosterone therapy: Prostate
safety. Aging Male 2004;7(4):304-311.
Ebert T, Jockenhovel F, Morales A et al. The current status of
therapy for symptomatic late-onset hypogonadism with
transdermal testosterone gel. Eur Urol 2005;47(2):137-146.
Eid J F. Sildenafil citrate: current clinical experience. [Review]
[19 refs]. Int J Impot Res 2000;12Suppl-6.
Eilenberg K L, Hoover A M, Rutherford M L et al. From
informed consent through database lock: An interactive clinical
trial conducted using the internet. Drug Inf J 2004;38(3):239­
251.
Emmick J T, Stuewe S R, Mitchell M. Overview of the
cardiovascular effects of tadalafil. Eur Heart J Suppl
2002;4(H):H32-H47.
Everaerd Walter. Male erectile disorder. O'Donohue, William
(Ed); Geer, James H (Ed) 1993;(1993):418
Fabbri A, Aversa A, Isidori A. Erectile dysfunction: An
overview. Hum Reprod Update 1997;3(5):455-466.
Fagan Peter. Psychogenic impotence in relatively young men.
Levine, Stephen B (Ed); Risen, Candace B (Ed); Althof, Stanley
E (Ed) 2003;(2003):473-Routledge.
Fazio L, Brock G. Erectile dysfunction: Management update.
CMAJ: Canadian Medical Association Journal
2004;170(9):1429-1437.
Feret B. Apomorphine: A sublingual dopamine agonist for the
treatment of erectile dysfunction. Hosp Formul 2000;35(7):573­
579.
Ferrario C M, Levy P. Sexual dysfunction in patients with
hypertension: implications for therapy. [Review] [49 refs]. J
Clin Hypertens 2002;4(6):424-432.
Foreman Mark M, Doherty Paul C. Experimental
approaches for the development of pharmacological
therapies for erectile dysfunction. Riley, Alan J (Ed);
Peet, Malcolm (Ed); Wilson, Catherine (Ed)
1993;(1993):235
Fricker J. The rise and fall of Viagra. Drug Discov
Today 2001;6(14):704-706.
Galle G, Trummer H. The etiology of erectile
dysfunction and mechanisms by which drugs improve
erection. Med Actual 2003;39(3):193-201.
Garber B. Inflatable penile prostheses for the
treatment of erectile dysfunction. Expert Review of
Medical Devices 2005;2(3):341-350.
Garcia-Reboll L, Mulhall J P, Goldstein I. Drugs for
the treatment of impotence. [Review] [98 refs]. Drugs
Aging 1997;11(2):140-151.
Gerber H R. Intrathecal morphine for chronic benign
pain. Baillieres Best Practice & Research in Clinical
Anaesthesiology 2003;17(3):429-442.
Ghofrani H A, Pepke-Zaba J, Barbera J A et al. Nitric
oxide pathway and phosphodiesterase inhibitors in
pulmonary arterial hypertension. J Am Coll Cardiol
2004;43(12 SUPPL.):68S-72S.
Gingell C. Use of intracavernosal alprostadil in
erectile dysfunction. Hospital Medicine (London)
1998;59(10):777
Gingell J C. New developments in self-injection
therapy for erectile dysfunction. [Review] [33 refs]. Br
J Urol 1998;81(4):599-603.
Gitlin Michael J. Effects of depression and
antidepressants on sexual functioning. Bull Menninger
Clin 1995;59(2):232-248.
Giuliano F. Apomorphine SL: Evolution of a centrally
acting treatment for erectile dysfunction. European
Urology Supplements 2002;1(3):1-3.
Giuliano F. Phosphodiesterase type 5 inhibition in
erectile dysfunction: An overview. Eur Heart J Suppl
2002;4(H):H7-H12.
Giuliano F, Varanese L. Tadalafil: A novel treatment
for erectile dysfunction. Eur Heart J Suppl
2002;4(H):H24-H31.
Gjertson C K, Walmsley K, Kaplan S A. Benign
prostatic hyperplasia: Now we can begin to tailor
treatment. Cleve Clin J Med 2004;71(11):857-880.
Gleave M, Evans C P. What's hot in the prostate?.
Prostate Cancer & Prostatic Diseases 2003;6(4):268­
271.
D-40